Eton Pharmaceuticals, Inc. ETON Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $79.95M+105% | $39.01M+23.3% | $31.64M+48.9% | $21.25M-2.7% | ||
| $37.21M+139% | $15.6M+47.4% | $10.58M+52.6% | $6.93M+148% | ||
| $42.74M+82.6% | $23.41M+11.2% | $21.06M+47.1% | $14.32M-24.8% | ||
| 53.5%-6.6pp | 60%-6.5pp | 66.6%-0.8pp | 67.4%-19.8pp | ||
| $7.77M— | —— | $3.32M-16.9% | $4M-35.9% | ||
| $35.82M+57.4% | $22.75M+20.2% | $18.93M+1.9% | $18.58M+29.9% | ||
| $43.58M+67.6% | $26.01M+16.9% | $22.25M-1.4% | $22.58M+9.9% | ||
| $43.58M+67.6% | $26.01M+16.9% | $22.25M-1.4% | $22.58M+9.9% | ||
| —— | —— | -$1.19M— | —— | ||
| —— | —— | —— | —— | ||
| —— | -$3.81M-453% | -$689K— | —— | ||
| —— | $15K-93.9% | $247K— | $0— | ||
| —— | -$3.82M-308% | -$936K— | —— | ||
| —— | —— | —— | —— | ||
| —— | -$0.16-433% | -$0.03— | —— | ||
| —— | —— | —— | —— | ||
| 107.6M+4.1% | 103.3M+0.8% | 102.5M+35.4% | 75.7M-24.4% | ||
| —— | —— | —— | —— | ||
| $79.95M+105% | $39.01M+23.3% | $31.64M+48.9% | $21.25M-2.7% | ||
| —— | -$3.74M-214% | -$1.19M— | —— | ||
| —— | -$2.59M-790% | -$291K— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s revenue?
- Eton Pharmaceuticals, Inc. (ETON) generated $86.9M in revenue over the trailing twelve months, up 79.9% year over year.
- Is Eton Pharmaceuticals, Inc. profitable?
- Eton Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $4.5M over the trailing twelve months, a -9.5% net margin.
- What are Eton Pharmaceuticals, Inc.'s profit margins?
- Gross margin is 54.8% and operating margin is -15.1%, with a -9.5% net margin.
- What is Eton Pharmaceuticals, Inc.'s earnings per share?
- Eton Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-0.06.
- Where does Eton Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
